Role of Inflammatory Markers and Doppler Parameters in Late-Onset Fetal Growth Restriction: A Machine Learning Approach

Active, not recruitingOBSERVATIONAL
Enrollment

240

Participants

Timeline

Start Date

January 31, 2024

Primary Completion Date

July 6, 2024

Study Completion Date

July 20, 2024

Conditions
Fetal Growth RestrictionInflammatory Response
Interventions
DIAGNOSTIC_TEST

Ultrasound measurement

The diagnosis of FGR was made according to the following Delphi criteria . EFW \<3rd percentile or EFW \<10th percentile with Doppler evidence of placental dysfunction (Umbilical artery Doppler (UA) pulsatility index (PI) \>95th percentile, absence of umbilical artery end-diastolic flow (UAEDF), or reverse-UAEDF and/or cerebroplacental ratio (CPR) \<5th percentile).

DIAGNOSTIC_TEST

Laboratory Tests and Inflammatory Markers

"The laboratory values were measured at the time of FGR diagnosis (between 32 and 37 weeks of pregnancy). After evaluation of hemoglobin (g/dl), leukocytes (103/μL), monocytes (103/μL), lymphocytes (103/μL), neutrophils (103/μL), platelets (103/μL) and albumin (g/dl), the inflammation values were calculated as follows: ;~* SII = Absolute platelet count (APC)\* Absolute neutrophil count (ANC) / Absolute lymphocyte count (ALC);~* SIRI = Absolute monocyte count (AMC) \* ANC/ ALC;~* NPAR = Proportion of neutrophils (in total leukocytes) (%) × 100/albumin (g/dL)."

Trial Locations (1)

06170

Etlik City Hospital, Ankara

All Listed Sponsors
lead

Ankara Etlik City Hospital

OTHER_GOV

NCT06372938 - Role of Inflammatory Markers and Doppler Parameters in Late-Onset Fetal Growth Restriction: A Machine Learning Approach | Biotech Hunter | Biotech Hunter